INTRODUCTION
============

Peptidylarginine deiminases (PADIs; EC 3.5.3.15) deiminate positively charged arginine residues in protein to neutral citrulline residues in a Ca^2+^-dependent manner. To date, 5 isotypes of PADIs (PADI types 1--4 and type 6) have been found, all of which display extensive mutual sequence homologies. The greatest difference between them is their tissue-specific expression (reviewed by [@b61-molcell-37-5-426-10]). PADI type 2 (PADI2) is the most widely expressed type, and is observed in skeletal muscle, the brain, the spleen, macrophages, and lymphocytes ([@b4-molcell-37-5-426-10]; [@b12-molcell-37-5-426-10]; [@b62-molcell-37-5-426-10]). PADI4 is expressed mainly in granulocytes ([@b4-molcell-37-5-426-10]; [@b15-molcell-37-5-426-10]; [@b42-molcell-37-5-426-10]) and monocytes ([@b41-molcell-37-5-426-10]; [@b63-molcell-37-5-426-10]). PADI4 has a nuclear localization sequence, and has been found to be present in the cell nucleus ([@b42-molcell-37-5-426-10]). It targets nuclear proteins, including histones and nucleophosmin/B23 ([@b15-molcell-37-5-426-10]; [@b42-molcell-37-5-426-10]).

This posttranslational modification (deimination or citrullination) triggers a reduction in the net charge of the substrates, a loss of potential ionic bonds, interference with H bonds, and unfolding ([@b54-molcell-37-5-426-10]). It may exert a substantial impact on the structure and function of proteins. Citrullination can also lead to increased proteolytic susceptibility. For example, citrullinated myelin basic protein is prone to be digested by aspartyl protease cathepsin D ([@b43-molcell-37-5-426-10]; [@b48-molcell-37-5-426-10]), citrullinated filaggrin and alpha enolase are prone to be digested by calpain-1 ([@b25-molcell-37-5-426-10]; [@b26-molcell-37-5-426-10]), and citrullinated vimentin is prone to be digested by calpains (reviewed by [@b65-molcell-37-5-426-10]). Vimentin, a well-known substrate of PADI2 ([@b19-molcell-37-5-426-10]), is an intermediate filament protein that is widely expressed in all mesenchymal cells and tissues ([@b17-molcell-37-5-426-10]). As in other intermediate filaments, the vimentin network spreads from the nucleus to the plasma membrane. It plays a critical role in maintaining cell and tissue integrity ([@b34-molcell-37-5-426-10]).

Numerous autoimmune and neurodegenerative diseases are associated with citrullination, such as rheumatoid arthritis (RA) ([@b10-molcell-37-5-426-10]; [@b12-molcell-37-5-426-10]), multiple sclerosis ([@b40-molcell-37-5-426-10]; [@b44-molcell-37-5-426-10]), Alzheimer disease ([@b23-molcell-37-5-426-10]), and Parkinson disease ([@b43-molcell-37-5-426-10]). RA is an autoimmune disease characterized by chronic symmetric destructive polyarthritis of the peripheral joints. Among the autoantibodies found in patients with RA, autoantibodies against citrullinated proteins such as anticitrullinated protein antibodies (ACPAs) are most specific for RA. Citrullinated vimentin is the target of anti-Sa autoantibodies, an ACPA, ([@b62-molcell-37-5-426-10]), and presents in immune complexes in the synovial fluid of RA patients with ACPAs ([@b58-molcell-37-5-426-10]) and in inflamed synovial tissues ([@b55-molcell-37-5-426-10]). It plays a crucial role in triggering specific autoantibody production and RA pathogenesis ([@b59-molcell-37-5-426-10]).

The activation of PADIs is frequently observed during terminal differentiation and apoptosis. Filaggrin citrullination is presumably an apoptotic event in terminally differentiated keratinocytes ([@b51-molcell-37-5-426-10]). In the calcium ionophore-induced apoptosis of macrophages, citrullinated vimentin is found localized around the periphery of the round nucleus, which is an early morphological sign of apoptosis ([@b3-molcell-37-5-426-10]). The citrullination of nuclear proteins has also been reported during apoptosis ([@b36-molcell-37-5-426-10]). In our previous study, we found that PADI4 overexpression induces apoptosis in HL-60 and Jurkat cells ([@b32-molcell-37-5-426-10]). In this study, we found that PADI2 overexpression induces apoptosis in activated Jurkat T cells, and we investigated the role of vimentin in PADI2-induced apoptosis.

MATERIALS AND METHODS
=====================

Cell culture and chemical materials
-----------------------------------

JK-Tet-On cells were grown in a 90% RPMI-1640 medium with 10% fetal bovine serum obtained from Gibco BRL (USA) at a temperature of 37°C in a humidified 5% CO~2~ environment. Ribonuclease A (RNase A), acridine orange and doxycycline (Dox), 12-O-tetradecanoylphorbol-13-acetate (TPA), and ionomycin (Ion) were purchased from Sigma (USA).

Human PADI2, mutant PADI2, and vimentin gene subcloning, PADI2 gene knockdown with shRNA, and cell transfection
---------------------------------------------------------------------------------------------------------------

Human PADI2 and vimentin cDNA were purchased from RZPD Deutsches Ressourcenzentrum für Genomforschung. The D180A mutant of PADI2 (mPADI2) was prepared with the QuikChange site-directed mutagenesis kit (Stratagene, USA), as previously described ([@b33-molcell-37-5-426-10]), and confirmed by DNA sequencing. The amino acid residue, Asp180, locates in the N-terminal Ca^2+^-binding site of PADI2 and is essential for catalysis. To amplify PADI2 cDNA, a sense primer (PADI2-s: 19-mer) was used consisting of a 5′ *Not*I site (underlined) and an 11-nt sequence (nt 65--75): 5′-[GCGGCCGC]{.ul}ATGCTGCGCGA-3′, and an antisense primer (PADI2-as: 18-mer) consisting of a 5′ *Sal*I site (underlined) and a 12-nt sequence (nt 1,441--1,430): 5′-[GTCGACC]{.ul}ACCCCAAAAGA-3′. Vimentin cDNA (encoding 466 amino acids) was amplified using a sense primer (VIM-s: 20-mer) consisting of a 5′ *Not*I site (underlined) and a 12-nt sequence (nt 292--303): 5′-[GCGGCCGC]{.ul}ATGTCCACCA GG-3′, and an antisense primer (VIM-as: 18-mer) consisting of a 5′ *Sal*I site (underlined) and a 12-nt sequence (nt 1,678--1,689): 5′-[GTCGAC]{.ul}TTCAAGGTCATC-3′. The polymerase chain reaction (PCR) product was ligated into a T vector, and was transformed in the *E. coli* strain JM109. The bacteria were grown overnight at 37°C, the plasmids were eluted, and the amplified plasmids were digested with *Not*I*-Sal*I and subcloned into the NotI-*Eco*RI site of pTRE2hyg for the Tet-On system (BD Biosciences Clontech, USA). Only the pTRE2hyg-PADI2, -mPADI2 or -VIM and pTRE2hyg vector were transfected into JK-Tet-On system cells (BD Biosciences, Clontech) by using calcium phosphate-mediated transfection for stable transfection selection. Stably transfected cells were selected with the antibiotic hygromycin (400 μg/ml). After approximately 3 weeks, hygromycin-resistant clones were screened for protein expression by using immunoblotting. *In vitro*, the promoter induction of the JK-Tet-On cell system was achieved by adding Dox to the growth medium. *PADI2* and *luciferase* shRNAs were purchased from the Nature RNAi Core Facility, Taipei, Taiwan (NRC). Expression plasmids for *PADI2* and *luciferase* shRNA were made in pLKO.1-puro vector. The targeted shRNA sequences for luciferase and human PADI2 were 5′-GCGGTTGCCAAGAGGTTCCAT-3′ and 5′-ACACCGTGATATTCCGGATTG-3′, respectively.

Cell viability, apoptotic cell death and acridine orange staining
-----------------------------------------------------------------

Living cells were counted using a trypan blue exclusion assay. The cell viability was calculated according to the number of viable cells from the experimental groups divided by those in the control group. To identify apoptotic characteristics, 5 × 10^4^ cells in a 10-μl cell suspension were mixed with an equal volume of acridine orange solution (10 μg/ml) in phosphate buffered saline (PBS) on each slide. Green fluorescence was detected and photographed using a fluorescence microscope (Olympus America, USA). Apoptotic cell death was calculated according to the number of fluorescent nuclei (apoptotic cells) divided by the total number of cells, counted in 6 randomly chosen high power fields.

DNA fragmentation analysis
--------------------------

The cells (5 × 10^6^) were harvested and lysed overnight in a digestion buffer (0.5% sarkosyl, 0.5 mg/ml proteinase K, 50 mM Tris-HCl, pH 8.0, and 10 mM EDTA) at 55°C. They were subsequently treated with 0.5 μg/ml RNase A for 2 h. The genomic DNA was extracted using phenol-chloroform-isoamyl alcohol, and was analyzed using gel electrophoresis at 50 V for 90 min with 2% agarose. Approximately 20 μg of genomic DNA was loaded in each well, visualized under ultraviolet (UV) light, and photographed.

Immunoblotting
--------------

To purify total proteins, the cells were lysed in cold lysis buffer (10% v/v glycerol, 1% v/v Triton X-100, 1 mM sodium orthovanadate, 1 mM EGTA, 10 mM NaF, 1 mM sodium pyrophosphate, 20 mM Tris, pH 7.9, 100 μM β-glycerophosphate, 137 mM NaCl, 5 mM EDTA, 1 mM PMSF, 10 μg/ml aprotinin, and 10 μg/ml leupeptin), and subsequently homogenized and centrifuged. The supernatants were boiled in a loading buffer and an aliquot corresponding to 100 μg of protein separated by SDS-PAGE. After blotting, the membranes were incubated with anti-PADI2 (MDBio), anticaspase-3 (Cell Signaling), anti-PARP (Cell Signaling), antivimentin (Santa Cruz), anticitrulline (Ups-tate), and anti-β-actin antibodies (Santa Cruz) for 6 h, and the second antibody labeled with horseradish peroxidase was adjacently incubated for 1 h. The antigen-antibody complexes were visualized using enhanced chemiluminescence (Amer-sham Pharmacia Biotech, USA).

Immunoprecipitation
-------------------

Protein extracts (500 μg per assay) were preabsorbed with 1 μg of antivimentin antibodies at 4°C for 1 h. Subsequently, protein A/G agarose was added at 4°C overnight. After extensive washing, immunoprecipitated proteins were harvested and analyzed using immunoblotting with anticitrulline and antivimentin antibodies.

Fluorescence and differential interference contrast microscopy
--------------------------------------------------------------

After stimulation, JK-Tet-On-Vector and JK-Tet-On-PADI2 cells (1 × 10^6^) were fixed in 2% paraformaldehyde at room temperature (RT) for 15 min, washed with PBS, and cytospun on coverslips. After blocking with 3% bovine serum albumin at RT for 2 h, the cells were stained with antivimentin antibodies (1:50) at 4°C overnight, washed with PBS, and then incubated with goat antimouse IgG conjugated with rhodamine antibodies (Santa Cruz) at 37°C for 2 h. The coverslips were mounted onto glass slides and examined using confocal microscopy.

Concentrated protein
--------------------

Following incubation, the conditioned media were collected and concentrated using an Amicon Ultra-15 centrifugal filtration device (Millipore), with a molecular weight cutoff set at 30 kDa.

Statistical analysis
--------------------

Statistical analysis for significant differences between the control and experimental groups was conducted using Student's *t-*test.

RESULTS
=======

PADI2 overexpression induces apoptosis in activated Jurkat cells
----------------------------------------------------------------

We generated a cell line that overexpressed the PADI2 transgene from a tetracycline-inducible promoter in an otherwise isogenic background ([@b14-molcell-37-5-426-10]). In brief, we respectively constructed PADI2, mPADI2 and vector genes into a Tet-On expression plasmid (pTRE2hyg), and then transfected them to parental JK-Tet-On cells, namely JK-Tet-On-PADI2, JK-Tet-On-mPADI2 and JK-Tet-On-Vector cells. We used a combination of 15 ng/ml TPA and 1 μM Ion to induce the activation of Jurkat cells. After treatment with 50 μM Dox for 6 h, and then activation by TPA/Ion for another 6 h, JK-Tet-On-PADI2 cells expressed greater levels of the PADI2 protein than did the JK-Tet-On-Vector cells ([Fig. 1A](#f1-molcell-37-5-426-10){ref-type="fig"}).

We observed the effects of PADI2 overexpression on the cell viability of JK-Tet-On-PADI2 cells and their counterparts after they were treated with 10 μM or 50 μM Dox for 6 h followed by TPA/Ion activation for 24 h. The data revealed that cell proliferation continued in all 3 groups of JK-Tet-On-Vector cells (i.e., + 50 μM Dox; + 10 μM Dox + TPA/Ion; + 50 μM Dox + TPA/Ion) and the group of JK-Tet-On-PADI2 cells treated with 50 μM Dox alone ([Fig. 1B](#f1-molcell-37-5-426-10){ref-type="fig"}). No statistical differences emerged among these 4 groups; in other words, PADI2 overexpression alone did not result in cell death, and did not influence cell proliferation within 24 h. Furthermore, no significant differences emerged for Jurkat cell activation or with varying Dox doses. However, when Jurkat cells with overexpressed PADI2 were activated (JK-Tet-On-PADI2 + 10 μM Dox + TPA/Ion, and JK-Tet-On-PADI2 + 50 μM Dox + TPA/Ion), cell viability decreased significantly in a time- and dose-dependent manner within 24 h ([Fig. 1B](#f1-molcell-37-5-426-10){ref-type="fig"}). In brief, PADI2 overexpression reduced the cell viability of activated Jurkat cells. In addition, we found a significant increase of apoptotic cell death of nonactivated Jurkat cells with PADI2 overexpression at 48 and 72 h (17% and 54% respectively), compared with JK-Tet-On-Vector cells. PADI2 knockdown did not result in cell death, and mutant PADI2 overexpression had a less apoptotic effect than the wild type ([Fig. 2](#f2-molcell-37-5-426-10){ref-type="fig"}).

The morphological changes of PADI2-overexpressed and - activated Jurkat cells included chromatin condensation, membrane blebbing and shrinkage, and apoptotic bodies ([Fig. 3A](#f3-molcell-37-5-426-10){ref-type="fig"}). Jurkat cells without PADI2 overexpression (JK-Tet-On-Vector + Dox + TPA/Ion) or without activation (JK-Tet-On-PADI2 + Dox) exhibited a normal living cell appearance ([Fig. 3A](#f3-molcell-37-5-426-10){ref-type="fig"}). DNA fragmentation ([Fig. 3B](#f3-molcell-37-5-426-10){ref-type="fig"}), caspase-3 activation, and PARP cleavage ([Fig. 3C](#f3-molcell-37-5-426-10){ref-type="fig"}) presented in the PADI2-overexpressed and -activated Jurkat cells (JK-Tet-On-PADI2 + Dox + TPA/Ion), but not in others. All these findings indicated that decreasing cell viability in activated Jurkat cells with PADI2 overexpression is caused by apoptosis.

Enhanced by cell activation, PADI2 overexpression increases the amount of citrullinated proteins, including citrullinated vimentin
----------------------------------------------------------------------------------------------------------------------------------

To explore the function of overexpressed PADI2, we detected citrullinated proteins and vimentin in JK-Tet-On cells. Intracellular citrullinated proteins were detected using immunoblotting with anticitrulline antibodies. Nonactivated Jurkat cells with PADI2 overexpression (JK-Tet-On-PADI2 + Dox) had more citrullinated proteins than their nonactivated counterparts (JK-Tet-On-Vector + Dox). When Jurkat cells with PADI2 overexpression were activated (JK-Tet-On-PADI2 + Dox + TPA/Ion), they had greater levels of citrullinated proteins than nonactivated Jurkat cells with overexpressed PADI2 (JK-Tet-On-PADI2 + Dox) ([Fig. 4A](#f4-molcell-37-5-426-10){ref-type="fig"}). We immunoprecipitated vimentin, and immunoblotted the precipitants with anticitrulline antibodies. Again, citrullinated vimentin increased 1.2 times in nonactivated PADI2-overexpressed cells (JK-Tet-On-PADI2 + Dox), and 2 times in activated and PADI2 overexpressed cells (JK-Tet-On-PADI2 + Dox + TPA/Ion) compared with the control ([Fig. 4B](#f4-molcell-37-5-426-10){ref-type="fig"}). This finding revealed that PADI2 protein, overexpressed by the transfected gene, was functional and deiminated intracellular substrates, including vimentin. The enzyme activity was further enhanced by Jurkat cell activation.

Vimentin is involved in PADI2-induced apoptosis of activated Jurkat cells
-------------------------------------------------------------------------

To investigate the role of vimentin in PADI2-induced apoptosis, we transiently transfected vimentin into JK-Tet-On PADI2 and JK-Tet-On-Vector cells for 24 h to force-express a greater amount of normal vimentin in cells ([Fig. 5A](#f5-molcell-37-5-426-10){ref-type="fig"}). Vimentin overexpression did not alter the cell viability or proliferation of activated Jurkat cells without PADI2 overexpression ([Fig. 5B](#f5-molcell-37-5-426-10){ref-type="fig"}). In activated Jurkat cells with PADI2 overexpression, however, cell viability increased significantly in cells with force-expressed vimentin compared with those without. Vimentin overexpression rescued a portion of Jurkat cells from apoptosis, which was induced by PADI2 overexpression ([Fig. 5B](#f5-molcell-37-5-426-10){ref-type="fig"}); that is, vimentin was involved in PADI2-induced apoptosis in activated Jurkat cells.

Vimentin is expressed on cell surfaces and secreted by activated Jurkat cells with overexpressed PADI2
------------------------------------------------------------------------------------------------------

[@b39-molcell-37-5-426-10] reported that vimentin is secreted by activated macrophages, and [@b7-molcell-37-5-426-10] indicated that it is partially exposed on the surface of apoptotic T cells. To investigate whether vimentin was expressed on cell surfaces and secreted during PADI2-induced apoptosis, we pretreated JK-Tet-On-Vector and JK-Tet-On-PADI2 cells with 50 μM Dox for 6 h, treated them with TPA/Ion, collected the supernatants at 12 h and 24 h, and harvested all the cells at 24 h.

PADI2-overexpressed and -activated Jurkat cells (JK-Tet-On-PADI2+Dox+TPA/Ion) revealed greater levels of immunostaining compared with their counterparts when treated with the antivimentin antibody combined with the rhodamine-conjugated anti-mouse secondary antibody ([Fig. 6](#f6-molcell-37-5-426-10){ref-type="fig"}). We merged the photographs obtained using differential interference contrast microscopy and fluorescence microscopy (VIM), and found that the binding sites of the antivimentin antibody were on the cell surfaces. These findings showed that vimentin was expressed on the cell surfaces of PADI2-overexpressed and -activated Jurkat cells while they were undergoing apoptosis.

We concentrated the supernatants by using a centrifugal filtration device with the molecular weight cutoff set at 30 kDa, and then analyzed them using immunoblotting with antivimentin antibodies. After activating JK-Tet-On-Vector cells, we found a greater amount of vimentin in the supernatant collected at 24 h than in that collected at 12 h ([Fig. 7](#f7-molcell-37-5-426-10){ref-type="fig"}). At 12 h, the supernatant of PADI2-overexpressed and -activated Jurkat cells had more vimentin than the supernatant of their counterparts ([Fig. 7](#f7-molcell-37-5-426-10){ref-type="fig"}); in other words, T-cell activation and PADI2 overexpression promoted the secretion of vimentin. However, at 24 h, the supernatant of PADI2-overexpressed and -activated Jurkat cells had less vimentin.

DISCUSSION
==========

Triggering the antigen-specific T-cell receptor (TcR)/CD3 complex initiates a cascade of signal transductions across the cell membrane, resulting in activation and proliferation. One signal transduction pathway involves a phospholipase C species that hydrolyzes phosphatidylinositol 4,5-bisphosphate and generates 2 second messengers, diacylglycerol and inositol 1,4,5-trisphosphate (reviewed by [@b1-molcell-37-5-426-10]). Diacylglycerol activates protein kinase C (PKC) ([@b22-molcell-37-5-426-10]; [@b45-molcell-37-5-426-10]). Inositol 1,4,5-trisphosphate releases Ca^2+^ from the endoplasmic reticulum, resulting in an increase in the intracellular concentration of free Ca^2+^ ([@b20-molcell-37-5-426-10]). Therefore, a TcR/CD3-induced cellular response involves an increase in cytosolic calcium concentration and protein kinase C activation. The phorbol ester TPA, which is structurally related to diacylglycerol, directly binds to, and activates, PKC ([@b9-molcell-37-5-426-10]). The calcium ionophore Ion stimulates the Ca^2+^ influx ([@b31-molcell-37-5-426-10]). Thus, the combination of TPA and Ion mimics the antigen-induced signal at the onset of lymphocyte activation ([@b2-molcell-37-5-426-10]; [@b56-molcell-37-5-426-10]).

PADI2 and PADI4 are the only 2 isotypes expressed in the synovial tissue of patients with RA and those with other arthri-tides. Inflammatory cells, including lymphocytes and monocytes, infiltrate the synovial tissue, and are a major source of PADI2 and PADI4. The expression levels of PADI2 and PADI4 are correlated with the intensity of inflammation ([@b12-molcell-37-5-426-10]). In our study, Jurkat T lymphocytes exhibited endogenous PADI2 protein. Using a combination of TPA and Ion to activate Jurkat cells, we found that activated Jurkat cells expressed greater levels of PADI2 and exhibited greater PADI enzyme activity (data not shown). The expression of endogenous PADI2 may be transcriptionally regulated by TPA, because 4 plausible Sp1 binding sites are located in the PADI2 promoter region ([@b11-molcell-37-5-426-10]; [@b27-molcell-37-5-426-10]). The PADI2-Tet-On system functioned successfully to express exogenous PADI2 in activated Jurkat cells ([Fig. 1A](#f1-molcell-37-5-426-10){ref-type="fig"}). Moreover, overexpressed PADI2 displayed enzyme activity, which we inferred by noting the production of more citrullinated proteins ([Fig. 4](#f4-molcell-37-5-426-10){ref-type="fig"}).

PADIs rely strongly on the presence of Ca^2+^ for activity. A typical concentration of cytosolic Ca^2+^ is approximately 10^−7^M, which is too low for PADI2 activity ([@b3-molcell-37-5-426-10]; [@b63-molcell-37-5-426-10]). The minimum Ca^2+^ concentration required for PADI2 activity is approximately 100-fold higher than that required for normal cytosolic Ca^2+^ ([@b53-molcell-37-5-426-10]). Although nonactivated Jurkat cells expressed endogenous and exogenous PADI2, most of the enzymes were inactivated because of the low cytosolic Ca^2+^ concentration. When the Jurkat cells were activated, raising the cytosolic Ca^2+^ concentration, they activated PADI2 to deiminate intracellular substrates. In addition, we observed that activated cells with overexpressed PADI2 presented the typical manifestations of apoptosis. This paper is the first to provide direct evidence that PADI2 overexpression induces apoptosis in activated Jurkat cells.

Citrullinated proteins are detected in the inflammatory synovial fluid both in patients with RA and in patients with spondyloarthritis ([@b28-molcell-37-5-426-10]). However, the presentation of intracellular citrullinated proteins in the synovium is specific for RA ([@b5-molcell-37-5-426-10]), and is colocalized with PADI2 ([@b10-molcell-37-5-426-10]). Numerous well-known or suspected intracellular substrates of PADI2 and PADI4 exist, such as vimentin ([@b3-molcell-37-5-426-10]; [@b63-molcell-37-5-426-10]), histones ([@b42-molcell-37-5-426-10]), nucleophosmin/B23 ([@b15-molcell-37-5-426-10]), the F-actin capping protein alpha 1 subunit, cathepsin D, beta-actin ([@b35-molcell-37-5-426-10]), aldolase, alpha-enolase, phosphoglyce-rate kinase 1, calreticulin, the 60-kDa heat shock protein, far upstream element-binding proteins 1 and 2 ([@b13-molcell-37-5-426-10]), glucose-6-phosphate isomerase ([@b57-molcell-37-5-426-10]), and IKKγ ([@b30-molcell-37-5-426-10]). Among these, vimentin is the major citrullinated protein in human monocytic leukemia THP-1 cells during macrophage differentiation ([@b19-molcell-37-5-426-10]). Our study revealed that vimentin is a target protein of PADI2 in Jurkat cells during activation and apoptosis, as reported in mouse peritoneal and human macrophages ([@b3-molcell-37-5-426-10]; [@b63-molcell-37-5-426-10]), as well as in human monocytic leukemia THP-1 cells ([@b19-molcell-37-5-426-10]). In addition to its mechanical and structural properties, vimentin plays a crucial role in adhesion, migration, survival, and cell signaling (reviewed in [@b18-molcell-37-5-426-10]; [@b64-molcell-37-5-426-10]). The exact mechanisms of vimentin functionality have not been fully elucidated, and have instead been attributed to the dynamic disassembly/assembly and spatial reorganization regulated by phosphorylation ([@b21-molcell-37-5-426-10]; [@b24-molcell-37-5-426-10]). PADI2 predominantly deiminates the nonalphahelical N-terminal head domain of vimentin, which is rich in arginine, serine, and threonine, and is prone to phosphorylation ([@b21-molcell-37-5-426-10]; [@b24-molcell-37-5-426-10]). Vimentin citrulli-nation results in the disassembly of vimentin filaments, the prevention of assembly ([@b21-molcell-37-5-426-10]), loss of functions, and the transformation of the fine network across the whole cell into amorphous clusters located around the nucleus ([@b3-molcell-37-5-426-10]; [@b19-molcell-37-5-426-10]).

The role of vimentin in apoptosis has been demonstrated in withaferin A (WFA)-induced apoptosis ([@b29-molcell-37-5-426-10]). WFA, a naturally derived bioactive compound, binds to vimentin by covalently modifying its cysteine residue, which is present in the highly conserved alpha-helical coiled coil 2B domain ([@b6-molcell-37-5-426-10]). It transforms vimentin filaments to punctate cytoplasmic aggregates that colocalize vimentin and F-actin ([@b6-molcell-37-5-426-10]). Caspases rapidly degrade vimentin after exposure to different proapoptotic stimuli, including through ionizing radiation, and Fas, TRAIL, tumor necrosis factor α (TNFα), and tamoxifen administration ([@b16-molcell-37-5-426-10]; [@b38-molcell-37-5-426-10]; [@b47-molcell-37-5-426-10]). The inhibition of vimentin degradation (by caspase inhibitors or the overexpression of caspase-resistant vimentin) abrogates WFA-induced apoptosis ([@b29-molcell-37-5-426-10]). If vimentin is degraded by activated caspases, potential proapoptotic fragments are released and substantially enhance apoptosis ([@b8-molcell-37-5-426-10]). A positive feedback loop forms, whereby activated caspases degrade vimentin, and these degraded fragments consequently activate caspases to amplify apoptosis.

Our findings showed that vimentin overexpression at least partially rescued PADI2-overexpressed and -activated Jurkat cells. Cells with greater levels of vimentin exhibited a greater ability to withstand the impact of citrullination, and avoid apoptosis; in other words, vimentin is involved in the mechanism of PADI2-induced apoptosis. The overexpression of PADI2 increased the amount of citrullinated proteins, including citrullinated vimentin. Citrullinated vimentin lost its normal functions, and was probably unfolded and degraded by calpains. Overall, the inferential mechanism of PADI2-induced apoptosis may contribute to the initiation of apoptotic signals through the loss of normal vimentin functions, the unfolded protein response or pro-apoptotic vimentin fragments.

Although vimentin is an intracellular protein, it is expressed on cell membranes under certain distinctive conditions such as by platelets and macrophages during activation ([@b39-molcell-37-5-426-10]; [@b46-molcell-37-5-426-10]) and by lymphocytes and neutrophils during apoptosis ([@b7-molcell-37-5-426-10]; [@b37-molcell-37-5-426-10]). Vimentin is partially exposed on the surface of apoptotic T cells, and binds human group IIA phospholipase A2 (PLA2) through its rod domain in a calcium-independent manner ([@b7-molcell-37-5-426-10]). The binding of these 2 proteins enhanced PLA2 activity, suggesting that vimentin may play a role in PLA2-mediated cellular arachidonic acid release. Vimentin is expressed on the surface of apoptotic neutrophils ([@b37-molcell-37-5-426-10]), and is cleaved by the neutrophil-specific pro-tease membrane-type 6 matrix metalloproteinase ([@b52-molcell-37-5-426-10]). Cleaved vimentin on the cell surface potently promotes phagocytosis, and functions as an "eat me" signal to macrophages. This shows another role of vimentin in increasing the phagocytic removal of neutrophils to resolve inflammation ([@b52-molcell-37-5-426-10]). Compatible with previous studies, we found that vimentin was expressed on the cell surface of PADI2-overexpressed and -activated Jurkat cells while they were undergoing apoptosis. However, our data cannot provide an answer as to whether PADI2 contributes to this cell-surface expression or whether expressed vimentin is citrullinated. Further in-depth investigation is required to answer these questions. Moreover, vimentin secretion can be triggered by activated macrophages ([@b39-molcell-37-5-426-10]). Vimentin secretion is blocked by antiinflammatory cytokine interleukin-10, but is triggered by proinflammatory cytokine TNFα. Extracellular vimentin is involved in bacterial killing and the generation of oxidative metabolites ([@b39-molcell-37-5-426-10]), and is a chemoattractant for monocytes ([@b52-molcell-37-5-426-10]). We found that vimentin was secreted by activated Jurkat cells, which were further enhanced by PADI2 overexpression in the initial 12 h of activation. However, the amount of vimentin in the supernatant of PADI2-overexpressed and -activated Jurkat cells decreased 24 h after activation. We found citrullinated vimentin in all of the supernatants (data not shown). However, we failed to demonstrate an explainable and consistent result, possibly because numerous proteases are present in the intracellular and extracellular spaces, such as caspases, calpains, and matrix metalloproteinases, which are activated during cell activation or apoptosis, and degrade vimentin.

T lymphocytes are central to the specific immune response, and following their activation, they are eliminated by a Fas-mediated cell death program ([@b49-molcell-37-5-426-10]). The presence of activated T cells in the inflamed synovium of patients with RA is a primary indicator of the disease, and apoptosis is a crucial mechanism for their elimination and the eventual resolution of inflammation ([@b49-molcell-37-5-426-10]; [@b50-molcell-37-5-426-10]). It is typically believed that apoptotic immune cells can undergo secondary necrosis and release their contents in the extracellular space when they are overly abundant or cannot be cleared normally. In an extracellular space with a high Ca^2+^ concentration, PADI2 and PADI4 citrullinate extracellular proteins, which are then exposed to the immune system and elicit the formation of ACPAs ([@b60-molcell-37-5-426-10]). Through artificially highlighting PADI2 and vimentin, we demonstrated that PADI2 and vimentin participate in the apoptotic mechanisms of active T lymphocytes. Even in the normal course of T-cell apoptosis, the secretion and surface expression of vimentin are possible ways of autoantigen presentation to the immune system.
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![Overexpression of PADI2 decreases cell viability of activated Jurkat cells. (A) JK-Tet-On-PADI2 and JK-Tet-On-Vector cells were pretreated with 50 μM doxycycline (Dox) for 6 h and treated with 15 ng/ml 12-O-tetradecanoylphorbol-13-acetate (TPA) plus 1 μM ionomycin (Ion) for 6 h. Cells were harvested and total proteins were extracted for immunoblotting with specific antibodies to PADI2 and β-Actin. (B) JK-Tet-On-PADI2 and JK-Tet-On-Vector cells were pretreated with 10 or 50 μM Dox for 6 h, and then treated with or without TPA/Ion. Cell viability was determined at indicated time points by trypan blue exclusion assay. \**P* \< 0.05 and \*\**P* \< 0.01.](molcell-37-5-426-10f1){#f1-molcell-37-5-426-10}

![Apoptotic cell death of JK-Tet-On-PADI2, -mPADI2, -shPA DI2 cells. JK-Tet-On-PADI2, JK-Tet-On-mPADI2 and JK-Tet-On-Vector cells were treated with 50 μM Dox. Parental JK-Tet-On cells were transfected by *PADI2* and *Luciferase* shRNA (JK-Tet-OnshPADI2 and JK-Tet-On-shLuciferase). Apoptotic cell death (% fluorescent and condensed nuclei) was determined at indicated time points. \**P* \< 0.05 and \*\*\**P* \< 0.001, compared with JK-Tet-On-Vector cells.](molcell-37-5-426-10f2){#f2-molcell-37-5-426-10}

![Overexpression of PADI2 induces apoptosis of activated Jurkat cells. JK-Tet-On-Vector and JK-Tet-On-PADI2 cells were pretreated with 50 μM Dox for 6 h and treated with or without TPA/Ion for 24 h. (A) Cells were stained with acridine orange and analyzed by using light microscope and fluorescent microscope. (B) DNA fragmentation was detected by using DNA gel electrophoresis. (C) Total proteins were extracted and analyzed by immunoblotting with anti-caspase-3 and anti-PARP antibodies. Molecular weight markers (kDa) are indicated on the right.](molcell-37-5-426-10f3){#f3-molcell-37-5-426-10}

![Jurkat cells with overexpressed PADI2 have more citrullinated proteins and citrullinated vimentin, and further enhanced by cell activation. (A) JK-Tet-On-Vector and JK-Tet-On-PADI2 cells were pretreated with or without Dox 50 μM for 6 h, and then treated with or without TPA/Ion for 6 h. Cells were harvested and total proteins were extracted for immunoblotting with anti-citrulline antibodies. (B) The cells were lysed, and the lysates were immunoprecipitated with anti-vimentin (VIM) antibodies. The immunoprecipitates were analyzed by immunoblotting with anti-vimentin and anti-citrulline (Cit) antibodies. Molecular weight markers (kDa) are indicated on the right.](molcell-37-5-426-10f4){#f4-molcell-37-5-426-10}

![Overexpression of vimentin attenuates the apoptotic effect of PADI2 on activated Jurkat cells. (A) JK-Tet-On-Vector and JK-Tet-On-PADI2 cells were transfected transiently with vimentin for 24 h. Cells were harvested and total proteins were extracted for immunoblotting with anti-vimentin and anti-actin antibodies. (B) Transfected and non-transfected cells were pretreated with 50 μM Dox for 6 h, and then treated with TPA/Ion for 24 h. Cell viability was determined by trypan blue exclusion assay. \**P* \< 0.05.](molcell-37-5-426-10f5){#f5-molcell-37-5-426-10}

![Vimentin is expressed on cell surfaces of activated Jurkat cells with overexpressed PADI2. JK-Tet-On-Vector and JK-Tet-On-PADI2 cells were pretreated with 50 μM Dox for 6 h, and then treated with TPA/Ion for 24 h. Cells were stained with anti-vimentin (VIM) antibody, followed by rhodamine-conjugated anti-mouse secondary antibody (red), observed and photographed by differential interference contrast microscopy (DIC) and fluorescence microscopy. Confocal merge showed the location of vimentin.](molcell-37-5-426-10f6){#f6-molcell-37-5-426-10}

![Vimentin presents in the supernatants of activated Jurkat cells. JK-Tet-On-Vector and JK-Tet-On-PADI2 cells were pretreated with 50 μM Dox for 6 h, and then treated with TPA/Ion. The super-natants were collected at 12 h and 24 h, concentrated and then analyzed by immunoblotting with anti-vimentin antibody.](molcell-37-5-426-10f7){#f7-molcell-37-5-426-10}
